Product Description
The global anastomosis assist device market was valued at $97.4 million in 2025. This is expected to increase over the forecast period at a CAGR of 1.9% to reach $111.2 million.
The full report suite on the global market for anastomosis assist device (AAD) includes devices used for joining two blood vessels, usually to restore continuity after resection, or to bypass an unresectable disease process.
The report includes data for 65+ countries across 7 different regions which include North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific and Africa.
Data Types Included
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2032, and Historical Data to 2022
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
Global Anastomosis Assist Device Market Trends
The use of anastomosis assist devices is increasingly viewed as a means of reducing procedural risk during beating-heart coronary artery bypass grafting (CABG), also known as off-pump CABG (OPCAB). By enabling proximal anastomosis without aortic clamping, AADs may lower the risk of embolic events and neurological complications, particularly in higher-risk patient populations. As a growing proportion of patients undergoing surgical revascularization present with advanced age, extensive aortic calcification, or multiple comorbidities, surgeons are more frequently adopting additional risk-mitigation tools. This shift is expected to support continued demand for anastomosis assist devices over the forecast period, even as overall CABG volumes remain constrained.
Global Anastomosis Assist Device Market Share Insights
- Getinge was the leader of the global anastomosis assist device market in 2025. Getinge derives its share from the HEARTSTRING® proximal seal systems used for performing proximal anastomosis. It is expected that the company will maintain its current market share in the coming years.
- Advanced Medical Solutions (AMS) in July of 2024 broadened its cardiovascular offerings by acquiring Peters Surgical, a French company specializing in sutures, clips, surgical adhesives and anastomosis technologies. Peters Surgical had earlier expanded its portfolio by acquiring Vitalitec in 2014, which brought the ENCLOSE® II Proximal Anastomosis Assist Device under its umbrella. The ENCLOSE® II device eliminates the need for partial aortic clamping by creating a stable, bloodless surgical field and supports up to three anastomoses per device. Marketed as a cost-effective alternative to Getinge’s HEARTSTRING®, ENCLOSE® II now enhances AMS’s comprehensive surgical solutions lineup, reinforcing its position in the cardiovascular and tissue repair sectors.
- B. Braun holds a notable share of the global anastomosis assist device market in 2025. The company offers the C-Port® Flex A, PAS-Port® and C-Port®, which are manufactured by AesDex LLC and distributed by Aesculap. Aesculap is the surgical division within the B. Braun family of companies. B. Braun is expected to maintain most of its current share over the coming years. Smaller companies with a larger focus on the anastomosis assist device market is thought to take some of B. Braun’s share.
Global Anastomosis Assist Device Market Segmentation Summary
- Anastomosis Assist Device Market
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2025 |
| Forecast | 2026-2032 |
| Historical Data | 2022-2024 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis for Top Competitors, Mergers & Acquisitions, Emerging Markets & Technologies, Key Analysis Updates. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
